Medical Science News

RSS

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).

19 Oct 2010

An overview on American College of Gastroenterology's Annual Scientific meeting

The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.

19 Oct 2010

Study evaluates collaborative nature of translational medicine

Taking a cue from the world of business-performance experts and baseball talent scouts, Penn Medicine translational medicine researchers are among the first to find a way to measure the productivity of collaborations in a young, emerging institute. They published their findings the most recent issue of Science Translational Medicine.

19 Oct 2010

Study finds process of going in and out of anesthesia as distinct neurobiological processes

A study presented at this year's Annual Meeting of the American Society of Anesthesiologists strengthens emerging evidence that the act of going under anesthesia and coming out of anesthesia are distinct neurobiological processes. It also found that the parietal region of the brain may play a critical role in how anesthesia suppresses consciousness.

19 Oct 2010

UPM's LIA group creates new DNA-based biological sensor for applications in genetic diagnostics

The Universidad Politécnica de Madrid's Artificial Intelligence Group (LIA), based at the Facultad de Informática, has created a new DNA-based biological sensor that has potential applications in the field of genetic diagnostics. The basic sensor design was presented at the 2010 Conference on Unconventional Computation.

19 Oct 2010

BD, Walter and Eliza Hall Institute collaborate to commercialize antibodies

The Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, has entered a collaboration with New Jersey based medical technology company BD to evaluate and potentially develop for research and diagnostic use some of the institute's reagents.

19 Oct 2010

Study: Women's labor experience tied to ethnicity and genetics

Results from a clinical study presented at ANESTHESIOLOGY 2010 suggest that a women's labor experience is tied to her ethnicity as well as genetics.

19 Oct 2010

6th Decade of the Mind Conference to be held in Singapore

A total of 15 world renowned cognitive scientists have been invited to share recent advances in their respective fields at the 6th Decade of the Mind Conference to be held at Fusionopolis from 18 - 20 October 2010. Jointly organised by A*STAR's Institute of High Performance Computing (IHPC), MINDEF's Defence Research & Technology Office (DRTech) and NUS's Temasek Laboratories, it is the first such conference in Asia to promote awareness of Cognitive Science research done in Asia and from around the world.

19 Oct 2010

Researchers discover how cocaine corrupts brains' reward center

Mount Sinai researchers have discovered how cocaine corrupts the brain and becomes addictive. These findings-the first to connect activation of specific neurons to alterations in cocaine reward-were published in Science on October 15. The results may help researchers in developing new ways of treating those addicted to the drug.

19 Oct 2010

Study investigates effectiveness of potential treatment for Non-alcoholic steatohepatitis

Estimates of the prevalence of liver disease suggest that one‐third of the United States population has non‐alcoholic fatty liver disease (NAFLD). NAFLD is now the most common cause for elevated liver function tests in the United States, a trend related to the obesity epidemic in this country. Non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD, can lead to cirrhosis and all its complications.

19 Oct 2010

Discovery of 4 new DNA 'hotspots' may aid in developing new therapies for psoriasis

Scientists at the University of Michigan Heath System and their collaborators have found four new DNA "hotspots" that may one day help guide new treatments for psoriasis, one of the most common autoimmune diseases in the country.

19 Oct 2010

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer's disease and other neurological disorders of the brain. A new Penn study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer's disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.

19 Oct 2010

Study: Gastric function and autonomic nervous system are impaired in obese individuals

Research on obesity examining the role of hormones and the autonomic functions of the digestive system was presented at the 75th Annual Scientific Meeting of the American CoIlege of Gastroenterology.

19 Oct 2010

Researchers identify new mechanism that could help develop effective chemotherapy drug

Information on proteins is critical for understanding how cells function in health and disease. But while regular proteins are easy to extract and study, it is far more difficult to gather information about membrane proteins, which are responsible for exchanging elements essential to our health, like copper, between a cell and its surrounding tissues.

19 Oct 2010

International investors take interest in Australia's biotechnology industry at ALSIS 2010

AusBiotech has kicked off its annual conference with a hugely successful Australasian Life Sciences Investment Summit 2010 in Melbourne today. The premier life science investment conference for Australia and the Asia-Pacific region attracted 150 investors from more than 100 organisations to hear 39 selected Australian biotechnology companies.

19 Oct 2010

Study observes interaction between HLA-C and ERAP1 genes in psoriasis

Genetic variants associated with increased susceptibility to psoriasis are reported in five papers published online this week in Nature Genetics. Psoriasis is a chronic and recurrent skin disease, and one of the most prevalent autoimmune diseases, with a global prevalence of 2-3%.

19 Oct 2010

Researchers report breakthrough studies in liver cell transplantation

Two research teams from the Okayama University Graduate School of Medicine (Okayama, Japan) have reported breakthrough studies in liver cell transplantation.

19 Oct 2010

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.

19 Oct 2010

Study finds IAP enzyme maintains normal microbial population in gastrointestinal system

An enzyme that keeps intestinal bacteria out of the bloodstream may also play an important role in maintaining the normal microbial population of the gastrointestinal system.

19 Oct 2010

Novel bioelectric signals can cause stem cells to trigger melanoma-like growth in pigment cells

Biologists at Tufts University School of Arts and Sciences have discovered that a change in membrane voltage in newly identified "instructor cells" can cause stem cells' descendants to trigger melanoma-like growth in pigment cells. The Tufts team also found that this metastatic transformation is due to changes in serotonin transport. The discovery could aid in the prevention and treatment of diseases like cancer and vitiligo as well as birth defects.

19 Oct 2010

Medical Science News

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

An overview on American College of Gastroenterology's Annual Scientific meeting

Study evaluates collaborative nature of translational medicine

Study finds process of going in and out of anesthesia as distinct neurobiological processes

UPM's LIA group creates new DNA-based biological sensor for applications in genetic diagnostics

BD, Walter and Eliza Hall Institute collaborate to commercialize antibodies

Study: Women's labor experience tied to ethnicity and genetics

6th Decade of the Mind Conference to be held in Singapore

Researchers discover how cocaine corrupts brains' reward center

Study investigates effectiveness of potential treatment for Non-alcoholic steatohepatitis

Discovery of 4 new DNA 'hotspots' may aid in developing new therapies for psoriasis

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Study: Gastric function and autonomic nervous system are impaired in obese individuals

Researchers identify new mechanism that could help develop effective chemotherapy drug

International investors take interest in Australia's biotechnology industry at ALSIS 2010

Study observes interaction between HLA-C and ERAP1 genes in psoriasis

Researchers report breakthrough studies in liver cell transplantation

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Study finds IAP enzyme maintains normal microbial population in gastrointestinal system

Novel bioelectric signals can cause stem cells to trigger melanoma-like growth in pigment cells

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News